ASX Penny Stocks Spotlight CleanSpace Holdings And Two Others To Consider

Following the recent RBA rate increase, the Australian market is poised for a flat opening with potential volatility as investors navigate mixed signals from global markets and domestic economic shifts. For those interested in exploring beyond well-known stocks, penny stocks present intriguing opportunities despite their vintage moniker. These smaller or newer companies can offer surprising value when backed by solid financials, and this article will spotlight three such examples on the ASX that demonstrate potential for stability and growth.

Here we highlight a subset of our preferred stocks from the screener.

CleanSpace Holdings (ASX:CSX)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: CleanSpace Holdings Limited designs, manufactures, and sells respirators and related products for industrial and healthcare environments globally, with a market cap of A$34.92 million.

Operations: The company's revenue is derived entirely from the design, manufacture, and sale of respirators and related products and services, totaling A$19.82 million.

Market Cap: A$34.92M

CleanSpace Holdings, with a market cap of A$34.92 million, reported revenues of A$19.82 million for the fiscal year ending June 30, 2026, marking stability in sales compared to the previous year. Despite being unprofitable with a net loss of A$1.25 million and negative return on equity (-6.74%), the company benefits from having no debt and sufficient cash runway for over three years based on current free cash flow. The management team is experienced with an average tenure of 3.1 years, and short-term assets comfortably cover both short-term (A$3.3M) and long-term liabilities (A$1.7M).

• Navigate through the intricacies of CleanSpace Holdings with our comprehensive balance sheet health report here.
• Explore CleanSpace Holdings' analyst forecasts in our growth report.

Infragreen Group (ASX:IFN)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Infragreen Group Limited operates in the recycling and waste recovery, as well as clean energy and transition sectors across Australia and New Zealand, with a market capitalization of A$135.40 million.

Operations: The company generates revenue of A$0.35 million from its strategic investments in sustainable infrastructure businesses.

Market Cap: A$135.4M

Infragreen Group Limited, with a market cap of A$135.40 million, is pre-revenue with earnings primarily from strategic investments in sustainable infrastructure. The company recently reported a net income of A$7.64 million for the year ending June 30, 2026, reversing a prior net loss and reflecting profitability driven by a significant one-off gain of A$4.1 million. Its price-to-earnings ratio is below industry average at 17.7x, indicating potential value for investors focused on commercial services sectors. Infragreen has no debt obligations and maintains strong asset coverage over both short-term (A$482.6K) and long-term liabilities (A$215.7K).

• Jump into the full analysis health report here for a deeper understanding of Infragreen Group.
• Review our growth performance report to gain insights into Infragreen Group's future.

Tyro Payments (ASX:TYR)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Tyro Payments Limited offers integrated payment solutions and value-added services in Australia, with a market cap of A$365.08 million.

Operations: The company's revenue is primarily derived from its Payments segment, which accounts for A$459.15 million, followed by the Banking segment at A$17.88 million.

Market Cap: A$365.08M

Tyro Payments Limited, with a market cap of A$365.08 million, has shown consistent revenue growth, reporting A$489.76 million for the year ending June 30, 2026. The company is debt-free and its short-term assets cover both short-term (A$175.6M) and long-term liabilities (A$58.5M). Earnings have grown by 19.7% over the past year but this rate is below its five-year average of 65.7%. Tyro's net profit margins have improved to 4.4%, up from last year's 3.7%. Despite a less experienced management team, it trades at a discount to estimated fair value by approximately 19%.

• Dive into the specifics of Tyro Payments here with our thorough balance sheet health report.
• Assess Tyro Payments' future earnings estimates with our detailed growth reports.

Summing It All Up

• Click here to access our complete index of 399 ASX Penny Stocks.
• Ready For A Different Approach? AI is about to change healthcare. These 132 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com